Mercer Global Advisors
AMRX icon

Mercer Global Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Mercer Global Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$743K Buy
42,911
+1,264
+3% +$17.3K ﹤0.01% 1979
2026
Q1 		$518K Sell
41,647
-24,050
-37% -$323K ﹤0.01% 1957
2025
Q4 		$828K Buy
65,697
+55,242
+528% +$632K ﹤0.01% 1561
2025
Q3 		$105K Buy
+10,455
New +$93.8K ﹤0.01% 2510

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mercer Global Advisors's AMRX Position: Q2 2026 in Review

Mercer Global Advisors increased its Amneal Pharmaceuticals (AMRX) stake by 3% in Q2 2026, buying an estimated $17.3K and bringing the position to 42,911 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

Mercer Global Advisors first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $828K in Q4 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Mercer Global Advisors held 42,911 shares of Amneal Pharmaceuticals worth $743K as of Q2 2026.
  • Mercer Global Advisors bought 1,264 Amneal Pharmaceuticals shares in Q2 2026, an estimated $17.3K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1979 holding.
  • Mercer Global Advisors first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Mercer Global Advisors's Amneal Pharmaceuticals position peaked at $828K in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.